Michael Gould to Positron-Emission Tomography
This is a "connection" page, showing publications Michael Gould has written about Positron-Emission Tomography.
Connection Strength
2.752
-
Facility-level analysis of PET scanning for staging among US veterans with non-small cell lung cancer. Chest. 2014 Apr; 145(4):839-847.
Score: 0.479
-
The use and misuse of positron emission tomography in lung cancer evaluation. Clin Chest Med. 2011 Dec; 32(4):749-62.
Score: 0.407
-
Disparities in lung cancer staging with positron emission tomography in the Cancer Care Outcomes Research and Surveillance (CanCORS) study. J Thorac Oncol. 2011 May; 6(5):875-83.
Score: 0.391
-
Positron emission tomography 18F-fluorodeoxyglucose uptake and prognosis in patients with surgically treated, stage I non-small cell lung cancer: a systematic review. J Thorac Oncol. 2009 Dec; 4(12):1473-9.
Score: 0.355
-
The five commandments of efficient and effective care in the initial evaluation of lung cancer. Curr Opin Pulm Med. 2016 07; 22(4):319-26.
Score: 0.140
-
Use of posttreatment imaging and biomarkers in survivors of early-stage breast cancer: Inappropriate surveillance or necessary care? Cancer. 2016 Mar 15; 122(6):908-16.
Score: 0.135
-
Use of imaging for staging of early-stage breast cancer in two integrated health care systems: adherence with a choosing wisely recommendation. J Oncol Pract. 2015 May; 11(3):e320-8.
Score: 0.129
-
Methods for staging non-small cell lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2013 May; 143(5 Suppl):e211S-e250S.
Score: 0.112
-
Evaluation of individuals with pulmonary nodules: when is it lung cancer? Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2013 May; 143(5 Suppl):e93S-e120S.
Score: 0.112
-
Evaluation of screening-detected lung nodules: minimising the risk of unnecessary biopsy and surgery. Thorax. 2011 Apr; 66(4):277-9.
Score: 0.097
-
PET scan 18F-fluorodeoxyglucose uptake and prognosis in patients with resected clinical stage IA non-small cell lung cancer. Chest. 2010 May; 137(5):1150-6.
Score: 0.089
-
Cost and outcomes of patients with solitary pulmonary nodules managed with PET scans. Chest. 2010 01; 137(1):53-9.
Score: 0.086
-
A comparison of the diagnostic accuracy of 18F-FDG PET and CT in the characterization of solitary pulmonary nodules. J Nucl Med. 2008 Feb; 49(2):179-85.
Score: 0.078
-
Clinical Equipoise and Shared Decision-making in Pulmonary Nodule Management. A Survey of American Thoracic Society Clinicians. Ann Am Thorac Soc. 2017 Jun; 14(6):968-975.
Score: 0.037
-
Use of [(18)F]Fluoro-2-deoxy-d-glucose Positron Emission Tomographic Imaging in the National Lung Screening Trial. Chest. 2016 09; 150(3):621-30.
Score: 0.035
-
Management of Pulmonary Nodules by Community Pulmonologists: A Multicenter Observational Study. Chest. 2015 Dec; 148(6):1405-1414.
Score: 0.034
-
Evidence for the treatment of patients with pulmonary nodules: when is it lung cancer?: ACCP evidence-based clinical practice guidelines (2nd edition). Chest. 2007 Sep; 132(3 Suppl):94S-107S.
Score: 0.019
-
Noninvasive staging of non-small cell lung cancer: ACCP evidenced-based clinical practice guidelines (2nd edition). Chest. 2007 Sep; 132(3 Suppl):178S-201S.
Score: 0.019